Non valvular atrial fibrillation
Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians
13
Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
11
Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol
10
Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
5
Original Article Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation
9
Characteristics of Pulmonary Vein Enlargement in Non Valvular Atrial Fibrillation Patients with Stroke
11
Original Article CHA2DS2-VASc can better predict short-term prognosis in acute ischemic stroke patients with non-valvular atrial fibrillation
7
Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study
7
Which method of left atrium size quantification is the most accurate to recognize thromboembolic risk in patients with non-valvular atrial fibrillation?
12
<p>Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation</p>
9
Management of non-valvular Atrial Fibrillation
25
Characteristics affecting oral anticoagulant therapy choice among patients with non valvular atrial fibrillation: a retrospective claims analysis
9
<p>Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study</p>
7
A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol
8
Rivaroxaban (Xarelto) for stroke prevention in non-valvular atrial fibrillation (riv-ah-rocks-ah-ban)
8
Evaluation of left atrial deformation to predict left atrial stasis in patients with non-valvular atrial fibrillation – a pilot-study
9
Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients
5
Unlabeled Uses: Prevention of stroke and systemic embolism in patients with non valvular atrial fibrillation.
9
Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
5
Common Questions and Answers on the Practical Use of Oral Anticoagulants in Non-Valvular Atrial Fibrillation
11